Identification of Glypican-3 as a potential metastasis suppressor gene in gastric cancer

被引：30

作者：

Han, Shiwei ^{[1
,2
,3
,4
]}

Ma, Xuemei ^{[1
,3
,4
]}

Zhao, Yanxia ^{[5
]}

Zhao, Hongying ^{[6
]}

Batista, Ana ^{[2
]}

Zhou, Sheng ^{[7
]}

Zhou, Xiaona ^{[1
,3
,4
]}

Yang, Yao ^{[1
,3
,4
]}

Wang, Tingting ^{[1
,3
,4
]}

Bi, Jingtao ^{[8
]}

Xia, Zheng ^{[9
]}

Bai, Zhigang ^{[1
,3
,4
]}

Garkavtsev, Igor ^{[2
]}

Zhang, Zhongtao ^{[1
,3
,4
]}

机构：

[1] Capital Med Univ, Beijing Friendship Hosp, Dept Gen Surg, Beijing, Peoples R China

[2] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA

[3] Beijing Key Lab Canc Invas & Metastasis Res, Beijing, Peoples R China

[4] Natl Clin Res Ctr Digest Dis, Beijing, Peoples R China

[5] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Ctr Canc, Wuhan, Peoples R China

[6] Capital Med Univ, Beijing Chaoyang Hosp, Dept Pathol, Beijing, Peoples R China

[7] Huazhong Univ Sci & Technol, Inst Pathol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China

[8] Peking Univ, Dept Gen Surg, Beijing Jishuitan Hosp, Med Coll 4, Beijing, Peoples R China

[9] Cent S Univ, Dept Surg, Xiangya Hosp, Changsha, Hunan, Peoples R China

来源：

ONCOTARGET | 2016年 / 7卷 / 28期

基金：

中国国家自然科学基金;

关键词：

gastric cancer; Glypican-3; metastasis; FoxM1; Erk1/2; GOLABI-BEHMEL-SYNDROME; FOXM1; OVERGROWTH; EXPRESSION; PATHWAYS; THERAPY; KINASE; TARGET; TUMORS; CELLS;

D O I：

10.18632/oncotarget.9763

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Gastric cancer is a prevalent tumor that is usually detected at an advanced metastatic stage. Currently, standard therapies are mostly ineffective. Here, we report that Glypican-3 (GPC3) is absent in invasive tumors and metastatic lymph nodes, in particular in aggressive and highly disseminated signet ring cell carcinomas. We demonstrate that loss of GPC3 correlates with poor overall survival in patients. Moreover, we show that absence of GPC3 causes up-regulation of MAPK/FoxM1 signaling and that blockade of this pathway alters cellular invasion. An inverse correlation between GPC3 and FoxM1 is also shown in patient samples. These data identify GPC3 as a potential metastasis suppressor gene and suggest its value as a prognostic marker in gastric cancer. Development of therapies targeting signaling downstream of GPC3 are warranted.

引用

页码：44406 / 44416

页数：11

共 50 条

[1] Inhibition of invasion and metastasis by glypican-3 in a syngeneic breast cancer model
Peters, MG
Farías, E
Colombo, L
Filmus, J
Puricelli, L
Joffé, EBD
BREAST CANCER RESEARCH AND TREATMENT, 2003, 80 (02) : 221 - 232
[2] Inhibition of Invasion and Metastasis by Glypican-3 in a Syngeneic Breast Cancer Model
M.G. Peters
E. Farías
L. Colombo
J. Filmus
L. Puricelli
E. Bal de Kier Joffé
Breast Cancer Research and Treatment, 2003, 80 : 221 - 232
[3] New tumor suppressor microRNAs target glypican-3 in human liver cancer
Cartier, Flora
Indersie, Emilie
Lesjean, Sarah
Charpentier, Justine
Hooks, Katarzyna B.
Ghousein, Amani
Desplat, Angelique
Dugot-Senant, Nathalie
Trezeguet, Veronique
Sagliocco, Francis
Hagedorn, Martin
Grosset, Christophe F.
ONCOTARGET, 2017, 8 (25) : 41211 - 41226
[4] Glypican-3 expression is markedly decreased in human gastric cancer but not in esophageal cancer
Zhu, ZW
Friess, H
Kleef, J
Wang, L
Wirtz, M
Zimmermann, A
Korc, M
Büchler, MW
AMERICAN JOURNAL OF SURGERY, 2002, 184 (01): : 78 - 83
[5] The Expression of Glypican-3 in Colorectal Cancer
Azizpour, Sonia
Ezati, Razieh
Saidijam, Massoud
Razavi, Amirnader Emami
Jalilian, Farid Azizi
Mahdavinezhad, Ali
Eslami, Hamid
Soltanian, Alireza
Mohammadpour, Hadiseh
Kamali, Fatemeh
Amini, Razieh
CYTOLOGY AND GENETICS, 2019, 53 (05) : 430 - 440
[6] The Expression of Glypican-3 in Colorectal Cancer
Sonia Azizpour
Razieh Ezati
Massoud Saidijam
Amirnader Emami Razavi
Farid Azizi Jalilian
Ali Mahdavinezhad
Hamid Eslami
Alireza Soltanian
Hadiseh Mohammadpour
Fatemeh Kamali
Razieh Amini
Cytology and Genetics, 2019, 53 : 430 - 440
[7] Gene Expression of Hepatocellular Carcinoma Reveals Glypican-3 Role as Potential Biomarker
Nastase, Anca
Bacalbasa, Nicolae
Ilie, Veronica
Florea, Raluca
Sorop, Andrei
Tica, Valeria
Paslaru, Liliana
Iacob, Razvan
Grigorie, Razvan
Herlea, Vlad
Dima, Simona
Popescu, Irinel
ROMANIAN BIOTECHNOLOGICAL LETTERS, 2014, 19 (05): : 9657 - 9665
[8] Glypican-3: A new target for cancer immunotherapy
Ho, Mitchell
Kim, Heungnam
EUROPEAN JOURNAL OF CANCER, 2011, 47 (03) : 333 - 338
[9] MAY GLYPICAN-3 BE A NOVEL BIOMARKER AND POTENTIAL THERAPEUTIC TARGET IN HEPATOCELLULAR CANCER?
Ivanova, Irina I.
JOURNAL OF IMAB, 2018, 24 (01): : 1936 - 1940
[10] Identification of glypican-3 as a novel tumor marker for melanoma
Nakatsura, T
Kageshita, T
Ito, S
Wakamatsu, K
Monji, M
Ikuta, Y
Senju, S
Ono, T
Nishimura, Y
CLINICAL CANCER RESEARCH, 2004, 10 (19) : 6612 - 6621

← 1 2 3 4 5 →